Fortis Hospitals Bengaluru Launches Preventive Genomics Clinic, Ushering a New Era in Precision Medicine

▴ Preventive Genomics Clinic Launch at Fortis Hospitals Bengaluru
Padma Shri & Padma Bhushan Prof. Padmanabhan Balaram, Former Director of IISc, Bengaluru, inaugurated the clinic on the occasion of World DNA Day.
Bengaluru, 23 April 2026: Fortis Hospitals, Bengaluru today announced the launch of its Preventive Genomics Clinic across its Bengaluru network, thus reinforcing its commitment to delivering patient-centric, preventive and precision-led care. The clinic was inaugurated by Prof. Padmanabhan Balaram, Padma Shri & Padma Bhushan, Former Director of IISc, Bengaluru, in the presence of senior clinicians, hospital leadership and distinguished guests.
This Preventive Genomics Clinic aims to offer advanced genetic testing, expert counselling and personalized treatment plans, enabling individuals to make informed healthcare decisions based on their genetic profile. By leveraging genomics, Fortis Clinicians seek to enable early detection of inherited conditions, accurate diagnosis of complex diseases, and more targeted, effective treatment strategies.
The clinic will offer a wide range of services, including:
  • Whole Genome & Exome Sequencing: In-depth analysis for diagnosing rare and undiagnosed conditions.
  • Hereditary Cancer Screening: Assessing inherited risk for breast, ovarian, colorectal, and other cancers.
  • Pharmacogenomics: Personalized drug response testing to optimize treatment efficacy.
  • Prenatal & Newborn Screening: Early detection of genetic disorders in infants and during pregnancy.
  • CardioGenomics: Specialized genetic testing for cardiovascular conditions crucial for families with a history of sudden cardiac arrest, unexplained heart failure, or congenital heart disease.
  • NeuroGenomics: Specialized genetic testing for patients with complex neurological disorders, using gene-based insights to improve diagnosis and personalize interventions for conditions like epilepsy, Parkinson’s and rare neurodevelopmental syndromes.
  • OrthoGenomics: Personalized diagnostics, risk assessment, and targeted therapies for conditions like osteoarthritis, osteoporosis, and sarcoma.
  • Genetic Counselling: Expert guidance to help patients and families understand test results and take informed decisions.
  • Cancer directed Genomic Testing: Advanced diagnostics for hematology and oncology cases.
Speaking at the launch, Prof. Padmanabhan Balaram, Padma Shri & Padma Bhushan, Former Director of IISc, Bengaluru, said, “I congratulate Fortis Hospitals on this important initiative. Genomics is playing an increasingly important role in shaping the future of healthcare by enabling deeper insights into disease mechanisms and individual risk profiles. Initiatives like this are critical in bridging advanced science with clinical practice, helping move healthcare towards a more preventive and personalized approach.”
Dr. Niti Krishna Raizada, Principal Director, Medical Oncology & Hemato-Oncology, Fortis Hospitals, Bengaluru said, “Many serious conditions, especially cancers, have a genetic link that can be identified early to avert the disease and mortality risk. Through Preventive Genomics Clinic, we aim to empower patients with knowledge of their risks and enable early timely intervention, improving outcomes and supporting preventive care.”
Dr Vivek Jawali, Chairman, Cardiac Sciences, Fortis Hospitals, Bengaluru said, “Genomics is transforming how we approach disease management, shifting from a one-size-fits-all approach to a personalized and precise care. This clinic, brings together multiple specialties to leverage genetic insights for better diagnosis and treatment outcomes.”
Dr. Ananth Rao, VP & Business Head, Fortis Hospitals, Bengaluru said, “With growing awareness around preventive healthcare, there is an increasing need for advanced diagnostics that help individuals understand their health risks early. This initiative strengthens our commitment to delivering accessible, patient-centric, and future-ready healthcare.”
Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026